Stasys

Seattle, United States Founded: 2013 • Age: 13 yrs
Provider of POC device for analyzing blood clotting disorders and platelet dysfunction
Request Access

About Stasys

Stasys is a company based in Seattle (United States) founded in 2013 by Nathan White, Robert Barry, and Nate Sniadecki.. Stasys has raised $2.85 million across 7 funding rounds from investors including HHS, DARPA and America’s Seed Fund. Stasys offers products and services including Atlas Platelet Strength Test and Shear Force Technology. Stasys operates in a competitive market with competitors including Hemosonics, HemoSense, Exactus, ClotChip and Atantares, among others.

  • Headquarter Seattle, United States
  • Founders Nathan White, Robert Barry, Nate Sniadecki
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Stasys Medical Corporation
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $2.85 M (USD)

    in 7 rounds

  • Latest Funding Round
    $1.11 M (USD), Grant

    Apr 19, 2021

  • Investors
    HHS

    & 6 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Stasys

Stasys offers a comprehensive portfolio of products and services, including Atlas Platelet Strength Test and Shear Force Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Rapid test measures platelet strength in blood to predict bleeding risks.

Enables reagent-free platelet activation for quick clinical assessments.

Funding Insights of Stasys

Stasys has successfully raised a total of $2.85M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $1.11 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 7
  • Last Round Grant — $1.1M
  • First Round

    (01 Jan 2014)

  • Investors Count 7
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2021 Amount Grant - Stasys Valuation

investors

HHS
Jul, 2019 Amount Grant - Stasys Valuation

investors

HHS
Jun, 2017 Amount Series A - Stasys Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Stasys

Stasys has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, DARPA and America’s Seed Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital fund backed by the US Government
Founded Year Domain Location
-
Founded Year Domain Location
Early-stage investments are made in Washington-based startups by WRF Capital.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Stasys

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Stasys

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Stasys Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Stasys

Stasys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hemosonics, HemoSense, Exactus, ClotChip and Atantares, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
IVD for hemostasis characterization
domain founded_year HQ Location
Rapid Point-of-Care Coagulation analyzer
domain founded_year HQ Location
POC diagnostics for fibrinolytic status assessment are developed.
domain founded_year HQ Location
Portable tests for blood coagulation analysis are developed.
domain founded_year HQ Location
Developer of precision medicines & smart diagnostic devices by fusing biochip and AI technologies
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Stasys

Frequently Asked Questions about Stasys

When was Stasys founded?

Stasys was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Where is Stasys located?

Stasys is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.

Who is the current CEO of Stasys?

Michael Rackley is the current CEO of Stasys.

Is Stasys a funded company?

Stasys is a funded company, having raised a total of $2.85M across 7 funding rounds to date. The company's 1st funding round was a Series A of $1.25M, raised on Jan 01, 2014.

What does Stasys do?

Stasys was founded in 2013 in Seattle, United States, as a medical device company focused on hematology and trauma care. A point-of-care device is being developed to identify trauma-induced coagulopathy, which causes uncontrolled bleeding in patients. The technology analyzes clotting disorders and platelet function to support rapid diagnosis in clinical settings. Operations center on device innovation for emergency medical applications.

Who are the top competitors of Stasys?

Stasys's top competitors include Hemosonics, Perosphere Technologies and Atantares.

What products or services does Stasys offer?

Stasys offers Atlas Platelet Strength Test and Shear Force Technology.

Who are Stasys's investors?

Stasys has 7 investors. Key investors include HHS, DARPA, America’s Seed Fund, The W Fund, and WRF Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available